Jean Volatier
Director of Finance/CFO chez INVENTIVA
Fortune : 537 123 $ au 31/03/2024
Provenance du réseau au premier degré de Jean Volatier
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
21
| Public Company | Biotechnology | 21 |
20
| Public Company | Pharmaceuticals: Major | 20 |
Université Paris Dauphine-PSL
17
| College/University | Other Consumer Services | 17 |
École Nationale Supérieure des Mines de Paris
8
| College/University | Other Consumer Services | 8 |
Laboratoires Fournier SAS
 Laboratoires Fournier SAS Pharmaceuticals: MajorHealth Technology Laboratoires Fournier SAS manufactures pharmaceutical preparations. The company was founded on July 10, 2007 and is headquartered in Rungis, France.
3
| Subsidiary | Pharmaceuticals: Major | 3 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Jean Volatier via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| ENZON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Citigroup Global Markets, Inc. (Broker)
 Citigroup Global Markets, Inc. (Broker) Investment Banks/BrokersFinance Citigroup Global Markets, Inc. (Broker) (CGMI-Broker) is the broker/dealer division of Citigroup Global Markets, Inc., an investment bank headquartered in New York City with additional offices across the US. The firm was founded in 2004 and is a subsidiary of Citigroup Financial Products, Inc., ultimately held by Citigroup, Inc. (NYSE: C). CGMI-Broker covers all market capitalizations of the major global indices and provides macro and quantitative analysis of global markets and sector trends. Their core focus of the group is to help investing clients make informed decisions by providing value-added, independent, insightful analysis. | Investment Banks/Brokers | Analyst-Equity Corporate Officer/Principal | |
| BANQUE MAROCAINE POUR LE COMMERCE ET L'INDUSTRIE | Regional Banks | Corporate Officer/Principal | |
| BIOINVENT INTERNATIONAL AB | Biotechnology | Director/Board Member | |
| University of Oxford | College/University | Undergraduate Degree | |
| Imperial College London | College/University | Graduate Degree Graduate Degree Undergraduate Degree | |
Bpifrance SA
 Bpifrance SA Finance/Rental/LeasingFinance Bpifrance SA provides aids and financial support to small and medium companies. Its solutions include loans, insurance, warranties, and equity investments. The creation of the BPI was formalized by Law no. 2012-1559 on 31 December 2012, amending Ordinance no. 2005-722 of June 29, 2005, relating to the creation of the public institution OSEO, which became EPIC BPI-Groupe then EPIC Bpifrance, and the public limited company OSEO (now Bpifrance). The company was founded in 1923 and headquartered in Maisons-Alfort, France. | Finance/Rental/Leasing | Chief Investment Officer | |
| University of Cambridge | College/University | Undergraduate Degree Masters Business Admin | |
21 Centrale Partners SAS
 21 Centrale Partners SAS Investment ManagersFinance 21 Centrale Partners SAS is a Private Equity firm, a subsidiary of 21 Invest SpA founded in 1998 by Gérard Pluvinet and Henry Huyghues-Despointes. 21 Centrale Partners is headquartered in Paris. | Investment Managers | Private Equity Analyst | |
| INSEAD | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University College London | College/University | Doctorate Degree Doctorate Degree | |
Ferring Pharmaceuticals, Inc.
 Ferring Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals, Inc. develops and markets fertility and endocrinology products. Its products include Bravelle, Repronex, Novarel, Acthrel and Desmopressin Acetate. The company's products are used in treatment of osteoarthritis, prostate cancer, and other infertility related diseases. Ferring Pharmaceuticals was founded in 1951 and is headquartered in Parsippany, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Bocconi | College/University | Undergraduate Degree | |
| University of the Witwatersrand | College/University | Doctorate Degree | |
| Université Paris 1 Panthéon-Sorbonne | College/University | Doctorate Degree Doctorate Degree | |
| Pfizer, Inc. /Angers & Val-de-Reuil Pharmaceutical Operations | Pharmaceuticals: Major | Corporate Officer/Principal President | |
| Sciences Po | College/University | Graduate Degree Graduate Degree Graduate Degree | |
| École Centrale Paris | College/University | Undergraduate Degree Undergraduate Degree | |
| ESSEC Business School | College/University | Chief Executive Officer Undergraduate Degree | |
| Ecole Polytechnique | College/University | Undergraduate Degree Undergraduate Degree | |
| Télécom Paris | College/University | Undergraduate Degree Undergraduate Degree | |
| École des Hautes Études Commerciales de Paris | College/University | Undergraduate Degree | |
| University of Strasbourg | College/University | Doctorate Degree Doctorate Degree | |
Cancer Research UK
 Cancer Research UK Miscellaneous Commercial ServicesCommercial Services Cancer Research UK provides cancer research services. It supports and undertakes research on the biology and causes of cancer and develops anti-cancer drugs. The firm also provides general information about cancer and types of treatments and funds projects that help patients cope with the side effects of cancer and its treatment. Its institute also operates an online portal CancerHelp UK that provides patient information. The company was founded in 2001 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
France Biotech Association
 France Biotech Association Miscellaneous Commercial ServicesCommercial Services France Biotech Association is an independent association founded in 1997 that brings together healthtech entrepreneurs and their expert partners. The non-profit company is based in Paris, France. The association actively contributes to meeting the many challenges of the healthtech industry, such as companies' financing, innovation-related taxes, regulatory and market access related issues. It offers concrete competition and solutions through its commissions and working groups to help startups and SMEs become international leaders capable of rapidly developing and bringing innovative solutions to patients. The French company was founded by Philippe Pouletty, Pascal Brandys, Denis J. Lucquin. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Apposite Capital LLP
 Apposite Capital LLP Investment ManagersFinance Apposite Capital LLP (Apposite Capital) is a private equity arm of Mizuho Financial Group, Inc. founded in 2016 by David Porter. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Investor | |
Sanofi Pasteur
 Sanofi Pasteur BiotechnologyHealth Technology Sanofi Pasteur SA develops, manufactures and supplies vaccines. It provides vaccines for bacterial and viral diseases, including diphtheria, typhoid fever, and poliomyelitis. The company was founded in 1990 and is headquartered in Lyon, France. | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| Ecole Superieure des Industries Agricoles et Alimentaires | College/University | Masters Business Admin | |
Novo Ventures 1 A/S
 Novo Ventures 1 A/S Investment ManagersFinance Novo Ventures (Novo Ventures) is a venture capital operating division of Novo Nordisk Fonden. It engages in investment activities. The firm was established in 1999, and is headquartered in Hellerup, Denmark. | Investment Managers | Corporate Officer/Principal | |
Novo Seeds
 Novo Seeds Investment ManagersFinance Novo Seeds (Novo Seeds) is a venture capital operating division of Novo Nordisk Fonden. The firm was established in 2007, and is headquartered in Hellerup, Denmark. | Investment Managers | Director of Investments | |
Biocodex Benelux
 Biocodex Benelux Pharmaceuticals: MajorHealth Technology Biocodex Benelux is a Belgian pharmaceutical company that has been operating in the healthcare market for over 60 years. The private company is based in Anderlecht, Belgium. The company offers a soothing cream specially formulated for a decimating massage of tired legs, which relieves, depletion, and tones the tired legs. The CEOs of the company are Jean-Marie Lefèvre and Francois Hublot. | Pharmaceuticals: Major | Chief Executive Officer | |
Pharcor SAS
 Pharcor SAS MiscellaneousMiscellaneous Pharcor provides financial services. The company is headquartered in Gentilly, France. | Miscellaneous | Chairman | |
Biocodex SAS
 Biocodex SAS Pharmaceuticals: MajorHealth Technology Biocodex SA develops and markets pharmaceutical products. Its services include Gastroentorology, Neurology and Psychiatry, pain treatment, and degenerative Osteoarthritis treatment. The company was founded in 1953 and is headquartered in Gentilly, France. | Pharmaceuticals: Major | Chairman | |
Abbott Laboratories Co.
 Abbott Laboratories Co. Pharmaceuticals: MajorHealth Technology Abbott Laboratories Co. provides health care services. The firm conducts research and manufactures products for human health through every life stage. Its products include nutrition, diagnostics, vascular and diabetes care. The company is headquartered in Saint-Laurent, Canada. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Human Resources Officer | |
Minervax ApS
 Minervax ApS Medical SpecialtiesHealth Technology Minervax ApS provides vaccine against streptococci. It utilizes fusion protein, which has proved to elicit good protective immunity. Its vaccine provides protective immunity against many clinically relevant GBS strains. The firm is engages in biotechnology, scientific and technical activities, and research and development. The company was founded in 2010 and is headquartered in Copenhagen, Denmark. | Medical Specialties | Director/Board Member | |
Pcovery ApS
 Pcovery ApS Pharmaceuticals: MajorHealth Technology Pcovery ApS develops drugs for treatment of invasive fungal infections. It discovers a new class of fungal therapy by targeting an essential and highly conserved component of the fungal cell membrane. The company was founded by Morten J. Buch-Pedersen, Michael Broberg Palmgren, Claus Olesen and Poul Nissen in 2009 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Director/Board Member | |
Galecto Biotech ApS
 Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Galecto Biotech ApS provides galectin modulators for the treatment of severe diseases, including fibrosis and cancer. Its products include galectin-3 inhibitors, fibrosis and literature. The company was founded by Tariq Sethi, Hans Thalsgard Schambye, Ulf Jorgen Nilsson, and Hakon Leffler in 2011 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Alliance for Research & Innovation in Health Industries | Corporate Secretary Chairman | ||
| OBSEVA SA | Pharmaceuticals: Major | Director/Board Member | |
| 4D PHARMA PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| LYSOGENE | Miscellaneous Commercial Services | Chief Executive Officer Director/Board Member | |
Glionova AB
 Glionova AB Pharmaceuticals: MajorHealth Technology Glionova AB develops cancer treatment drugs. The firm is a drug discovery and development company. It offers GLN-1001 product. The company was founded by Lars G. J. Hammarström and Patrik Ernfors in 2014 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
| TME PHARMA N.V. | Biotechnology | Director/Board Member | |
Mylan Laboratories SAS
 Mylan Laboratories SAS Pharmaceuticals: MajorHealth Technology Mylan Laboratories SAS operates as a pharmaceutical company. The company is headquartered in Suresnes, France. | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal Corporate Officer/Principal | |
TargEDys SA
 TargEDys SA BiotechnologyHealth Technology TargEDys SA develops microbiome-based solutions for appetite regulation. It provides humanity with easy means of regulating their eating behaviors for the third millennium. The company was founded by Pierre Dechelotte and Gregory Lambert 2011 and is headquartered in Paris, France. | Biotechnology | Director/Board Member Director/Board Member | |
Affinicon ApS
 Affinicon ApS Pharmaceuticals: MajorHealth Technology Affinicon ApS operates as a biotechnology company. It develops combinatory drugs for treatment of diseases such as inflammation, infections, and certain forms of cancer. The firm exploits a novel platform technology for targeted delivery of known drugs to macrophages. The company was founded by Niels Jonas Heilskov Graversen on July 4, 2013 and is headquartered in Aarhus, Denmark. | Pharmaceuticals: Major | Director/Board Member | |
Inversago Pharma, Inc.
 Inversago Pharma, Inc. Pharmaceuticals: MajorHealth Technology Inversago Pharma, Inc. develops novel gastrointestinal drugs. The company was founded by Fran?ois Ravenelle in and is headquartered in Montreal, Canada. | Pharmaceuticals: Major | Director/Board Member | |
Vivet Therapeutics SAS
 Vivet Therapeutics SAS BiotechnologyHealth Technology Vivet Therapeutics SAS develops novel gene therapy treatments for inherited metabolic diseases. The firm offers its services under the categorizers of Biopharma, Biotechnology and Health Care. The company was founded by Jean-Philippe Combal, Gloria Gonzalez-Aseguinolaza and Jens Kurth on July 26, 2016 and is headquartered in Paris, France. | Biotechnology | Director of Finance/CFO |
Statistiques
Internationale
| France | 24 |
| Royaume-Uni | 8 |
| Danemark | 7 |
| Etats-Unis | 5 |
| Suède | 3 |
Sectorielle
| Health Technology | 22 |
| Consumer Services | 18 |
| Finance | 8 |
| Commercial Services | 4 |
| Miscellaneous | 2 |
Opérationnelle
| Director/Board Member | 212 |
| Corporate Officer/Principal | 106 |
| Independent Dir/Board Member | 44 |
| Graduate Degree | 40 |
| Undergraduate Degree | 35 |
Relations les plus connectées
| Insiders | |
|---|---|
| Pierre Césarini | 43 |
| Chris Buyse | 39 |
| Nanna Liebach Lüneborg | 29 |
| Julien Billot | 22 |
| Isabelle de Cremoux | 21 |
| Claude Bertrand | 20 |
| Hugues de Saint Germain | 19 |
| Martine George | 18 |
| Xiao Qin Lu | 15 |
| Marie Paule Richard | 15 |
| Christopher Gregory Newton | 15 |
| Karen Pignet-Aiach | 12 |
| Daniel Emile Pinto | 12 |
| David Nikodem | 11 |
| Annick Schwebig | 11 |
- Bourse
- Insiders
- Jean Volatier
- Connexions Sociétés
